Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1972 Mar;25(3):252–258. doi: 10.1136/jcp.25.3.252

Oral contraceptives and tryptophan metabolism: Effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone

D P Rose 1, P W Adams 1
PMCID: PMC477273  PMID: 5018716

Abstract

The effect upon tryptophan metabolism of the use of combined oestrogen-progestagen oral contraceptives containing a low (0·05 mg) dose of oestrogen, or of the continuous administration of megestrol acetate, has been studied by determining the excretion of tryptophan metabolites in urine collected after a 2 g oral dose of the amino acid.

An investigation of 10 women before being given oral contraceptives and after 21 days and three months of their use showed that xanthurenic acid excretion is increased within 21 days and that by three months the urinary levels of xanthurenic acid, kynurenine, 3-hydroxykynurenine, and 3-hydroxyanthranilic acid may all be elevated.

Ten other women studied after taking a combined type of oral contraceptive for six months or longer excreted significantly higher levels of all four metabolites than did those who had been treated with these steroids for only three months. The abnormal urinary excretion of tryptophan metabolites was completely reversed by treatment with pyridoxine hydrochloride, 20 mg daily for one month.

Studies of four women when they were taking an oestrogen-containing oral contraceptive and at intervals after they had discontinued its use showed that abnormal tryptophan metabolism may persist for three months or longer.

Megestrol acetate, a progestagen used as an oral contraceptive, was found to have no significant effect upon tryptophan metabolism.

The possible clinical significance of the effects of oral contraceptives upon tryptophan metabolism is discussed.

Full text

PDF
252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BETT I. M. Metabolism of tryptophan in rheumatoid arthritis. Ann Rheum Dis. 1962 Mar;21:63–69. doi: 10.1136/ard.21.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bole G. G., Jr, Friedlaender M. H., Smith C. K. Rheumatic symptoms and serological abnormalities induced by oral contraceptives. Lancet. 1969 Feb 15;1(7590):323–326. doi: 10.1016/s0140-6736(69)91294-x. [DOI] [PubMed] [Google Scholar]
  3. Braidman I. P., Rose D. P. Effects of sex hormones on three glucocorticoid-inducible enzymes concerned with amino acid metabolism in rat liver. Endocrinology. 1971 Nov;89(5):1250–1255. doi: 10.1210/endo-89-5-1250. [DOI] [PubMed] [Google Scholar]
  4. Brown R. R., Rose D. P., Price J. M., Wolf H. Tryptophan metabolism as affected by anovulatory agents. Ann N Y Acad Sci. 1969 Sep 30;166(1):44–56. doi: 10.1111/j.1749-6632.1969.tb46372.x. [DOI] [PubMed] [Google Scholar]
  5. Curzon G. Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry. 1969 Dec;115(529):1367–1374. doi: 10.1192/bjp.115.529.1367. [DOI] [PubMed] [Google Scholar]
  6. Di Paola G., Robín M., Nicholson R. Estrogen therapy and glucose tolerance test. Am J Obstet Gynecol. 1970 May 1;107(1):124–132. doi: 10.1016/s0002-9378(16)33900-x. [DOI] [PubMed] [Google Scholar]
  7. Doar J. W., Wynn V. Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels. Br Med J. 1970 Jan 17;1(5689):149–152. doi: 10.1136/bmj.1.5689.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heeley A. F. The effect of pyridoxine on tryptophan metabolism in phenylketonuria. Clin Sci. 1965 Dec;29(3):465–473. [PubMed] [Google Scholar]
  9. Kotake Y., Sotokawa T., Murakami E., Hisatake A., Abe M. Studies on the xanthurenic acid-insulin complex. II. Physiological activities. J Biochem. 1968 May;63(5):578–581. doi: 10.1093/oxfordjournals.jbchem.a128816. [DOI] [PubMed] [Google Scholar]
  10. Larsson-Cohn U., Tengström B., Wide L. Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment. Acta Endocrinol (Copenh) 1969 Oct;62(2):242–250. doi: 10.1530/acta.0.0620242. [DOI] [PubMed] [Google Scholar]
  11. Luhby A. L., Davis P., Murphy M., Gordon M., Brin M., Spiegel H. Pyridoxine and oral contraceptives. Lancet. 1970 Nov 21;2(7682):1083–1083. doi: 10.1016/s0140-6736(70)90312-0. [DOI] [PubMed] [Google Scholar]
  12. Mason M., Ford J., Wu H. L. Effects of steroid and nonsteroid metabolites on enzyme conformation and pyridoxal phosphate binding. Ann N Y Acad Sci. 1969 Sep 30;166(1):170–183. doi: 10.1111/j.1749-6632.1969.tb54267.x. [DOI] [PubMed] [Google Scholar]
  13. McMillan M. THE IDENTIFICATION OF A FLUORESCENT REDUCING SUBSTANCE IN THE URINE OF PATIENTS WITH RHEUMATOID ARTHRITIS: THE EXCRETION OF 3-HYDROXYANTHRANILIC ACID IN THIS AND OTHER CONDITIONS. J Clin Pathol. 1960 Mar;13(2):140–148. doi: 10.1136/jcp.13.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mears E., Vessey M. P., Andolsek L., Oven A. Preliminary evaluation of four oral contraceptives containing only progestogens. Br Med J. 1969 Jun 21;2(5659):730–734. doi: 10.1136/bmj.2.5659.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Price J. M., Brown R. R., Yess N. Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Adv Metab Disord. 1965;2:159–225. doi: 10.1016/b978-1-4831-6750-3.50009-3. [DOI] [PubMed] [Google Scholar]
  17. Price J. M., Thornton M. J., Mueller L. M. Tryptophan metabolism in women using steroid hormones for ovulation control. Am J Clin Nutr. 1967 May;20(5):452–456. doi: 10.1093/ajcn/20.5.452. [DOI] [PubMed] [Google Scholar]
  18. Rose D. P. Aspects of tryptophan metabolism in health and disease: a review. J Clin Pathol. 1972 Jan;25(1):17–25. doi: 10.1136/jcp.25.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rose D. P., McGinty F. The influence of adrenocortical hormones and vitamins upon tryptophan metabolism in man. Clin Sci. 1968 Aug;35(1):1–9. [PubMed] [Google Scholar]
  20. Rose D. P. The influence of oestrogens on tryptophan metabolism in man. Clin Sci. 1966 Oct;31(2):265–272. [PubMed] [Google Scholar]
  21. Scowen E. F. Oral contraceptives containing oestrogens. Br Med J. 1969 Dec 20;4(5685):744–744. doi: 10.1136/bmj.4.5685.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Spiera H., Plotz C. M. Rheumatic symptoms and oral contraceptives. Lancet. 1969 Mar 15;1(7594):571–572. doi: 10.1016/s0140-6736(69)91977-1. [DOI] [PubMed] [Google Scholar]
  23. Toseland P. A., Price S. Tryptophan and oral contraceptives. Br Med J. 1969 Mar 22;1(5646):777–777. doi: 10.1136/bmj.1.5646.777-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. WALSH M. P. SEPARATION AND ESTIMATION OF TRYPTOPHAN-NICOTINIC ACID METABOLITES IN URINE BY THIN-LAYER CHROMATOGRAPHY. Clin Chim Acta. 1965 Mar;11:263–267. doi: 10.1016/0009-8981(65)90072-0. [DOI] [PubMed] [Google Scholar]
  25. Winston F. Oral contraceptives and depression. Lancet. 1969 Jun 14;1(7607):1209–1209. doi: 10.1016/s0140-6736(69)92185-0. [DOI] [PubMed] [Google Scholar]
  26. Wynn V., Doar J. W. Some effects of oral contraceptives on carbohydrate metabolism. Lancet. 1966 Oct 1;2(7466):715–719. doi: 10.1016/s0140-6736(66)92978-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES